Bob Gibbs sold Aravive, Inc. (ARAV) [ST] (ARAV)
Bob Gibbs (R-OH), a U.S. Representative, has disclosed 1 trade in Aravive, Inc. (ARAV) [ST] (ARAV) since 2018, a single sale, worth an estimated $112 in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Bob Gibbs sold $158.65 of Aravive, Inc. (ARAV) [ST] (ARAV) on December 28, 2018. Since that trade, ARAV is up +0.00% against the S&P 500 up +233.80%, an outperformance of -233.80%.
Data updated
Bob Gibbs's ARAV trades vs the price
ARAV is up +0.00% since Bob Gibbs sold on December 28, 2018, versus +233.80% for the S&P 500.
Performance since this trade
All Bob Gibbs ARAV trades
Bob Gibbs & ARAV trading FAQ
Is it legal for Bob Gibbs to trade Aravive, Inc. (ARAV) [ST] (ARAV) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Aravive, Inc. (ARAV) [ST] (ARAV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Bob Gibbs sell ARAV?
Bob Gibbs disclosed a sale of $158.65 of Aravive, Inc. (ARAV) [ST] (ARAV) on December 28, 2018, according to public STOCK Act filings.
How has ARAV performed since Bob Gibbs's trade?
Since Bob Gibbs sold ARAV on December 28, 2018, the stock is up +0.00%, versus +233.80% for the S&P 500 over the same period, an outperformance of -233.80%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ARAV trades?
Quantellect tracks every disclosed congressional trade in Aravive, Inc. (ARAV) [ST] (ARAV) on the Aravive, Inc. (ARAV) [ST] congressional trading page, which aggregates filings across all members of Congress.
Bob Gibbs's ARAV tradesAll congressional filings for Aravive, Inc. (ARAV) [ST]Bob Gibbs's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.